Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 18/20 | 0.79 |
| ▸ | ITGA4 | P13612 | 18/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7116351 | 1.00 | ITGB1 (0.79) | ITGB1ITGA4ALDH1A1MEN1KMT2A | |
| SCHEMBL6293861 | 0.89 | ITGB1 (0.75) | ITGB1ITGA4ALDH1A1 | |
| SCHEMBL6293848 | 0.89 | ITGB1 (1.00) | ITGB1ITGA4ALDH1A1 | |
| SCHEMBL6297087 | 0.86 | ITGB1 (0.68) | ITGB1ITGA4ALDH1A1 | |
| SCHEMBL6292462 | 0.86 | ITGA4 (1.00) | ITGB1ITGA4 | |
| SCHEMBL21376381 | 0.85 | ITGB1 (0.67) | ITGB1ITGA4 | |
| SCHEMBL6297805 | 0.85 | ITGB1 (1.00) | ITGB1ITGA4 | |
| SCHEMBL19426617 | 0.83 | ITGB1 (0.60) | ITGB1ITGA4 | |
| SCHEMBL19426616 | 0.83 | ITGB1 (0.60) | ITGB1ITGA4 | |
| SCHEMBL19426780 | 0.81 | ITGB1 (0.58) | ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1303492-A2 | AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS ALPHA 4 INTEGRIN ANTAGONISTS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002002556-A2 | AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2002-01-10 | — | — | WO | disclosed |